Index
1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Mantle Cell Lymphoma Treatment Market Size Growth Rate by Type: 2019 VS 2023 VS 2030
1.2.2 Acalabrutinib
1.2.3 JCAR-017
1.2.4 JNJ-64052781
1.2.5 Acalisib
1.2.6 IGN-002
1.2.7 IMGN-529
1.2.8 AFM-11
1.2.9 Others
1.3 Market by Application
1.3.1 Global Mantle Cell Lymphoma Treatment Market Growth by Application: 2019 VS 2023 VS 2030
1.3.2 Hospital
1.3.3 Clinic
1.3.4 Others
1.4 Study Objectives
1.5 Years Considered
1.6 Years Considered
2 Global Growth Trends
2.1 Global Mantle Cell Lymphoma Treatment Market Perspective (2019-2030)
2.2 Mantle Cell Lymphoma Treatment Growth Trends by Region
2.2.1 Global Mantle Cell Lymphoma Treatment Market Size by Region: 2019 VS 2023 VS 2030
2.2.2 Mantle Cell Lymphoma Treatment Historic Market Size by Region (2019-2024)
2.2.3 Mantle Cell Lymphoma Treatment Forecasted Market Size by Region (2025-2030)
2.3 Mantle Cell Lymphoma Treatment Market Dynamics
2.3.1 Mantle Cell Lymphoma Treatment Industry Trends
2.3.2 Mantle Cell Lymphoma Treatment Market Drivers
2.3.3 Mantle Cell Lymphoma Treatment Market Challenges
2.3.4 Mantle Cell Lymphoma Treatment Market Restraints
3 Competition Landscape by Key Players
3.1 Global Top Mantle Cell Lymphoma Treatment Players by Revenue
3.1.1 Global Top Mantle Cell Lymphoma Treatment Players by Revenue (2019-2024)
3.1.2 Global Mantle Cell Lymphoma Treatment Revenue Market Share by Players (2019-2024)
3.2 Global Mantle Cell Lymphoma Treatment Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.3 Players Covered: Ranking by Mantle Cell Lymphoma Treatment Revenue
3.4 Global Mantle Cell Lymphoma Treatment Market Concentration Ratio
3.4.1 Global Mantle Cell Lymphoma Treatment Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Mantle Cell Lymphoma Treatment Revenue in 2023
3.5 Mantle Cell Lymphoma Treatment Key Players Head office and Area Served
3.6 Key Players Mantle Cell Lymphoma Treatment Product Solution and Service
3.7 Date of Enter into Mantle Cell Lymphoma Treatment Market
3.8 Mergers & Acquisitions, Expansion Plans
4 Mantle Cell Lymphoma Treatment Breakdown Data by Type
4.1 Global Mantle Cell Lymphoma Treatment Historic Market Size by Type (2019-2024)
4.2 Global Mantle Cell Lymphoma Treatment Forecasted Market Size by Type (2025-2030)
5 Mantle Cell Lymphoma Treatment Breakdown Data by Application
5.1 Global Mantle Cell Lymphoma Treatment Historic Market Size by Application (2019-2024)
5.2 Global Mantle Cell Lymphoma Treatment Forecasted Market Size by Application (2025-2030)
6 North America
6.1 North America Mantle Cell Lymphoma Treatment Market Size (2019-2030)
6.2 North America Mantle Cell Lymphoma Treatment Market Growth Rate by Country: 2019 VS 2023 VS 2030
6.3 North America Mantle Cell Lymphoma Treatment Market Size by Country (2019-2024)
6.4 North America Mantle Cell Lymphoma Treatment Market Size by Country (2025-2030)
6.5 United States
6.6 Canada
7 Europe
7.1 Europe Mantle Cell Lymphoma Treatment Market Size (2019-2030)
7.2 Europe Mantle Cell Lymphoma Treatment Market Growth Rate by Country: 2019 VS 2023 VS 2030
7.3 Europe Mantle Cell Lymphoma Treatment Market Size by Country (2019-2024)
7.4 Europe Mantle Cell Lymphoma Treatment Market Size by Country (2025-2030)
7.5 Germany
7.6 France
7.7 U.K.
7.8 Italy
7.9 Russia
7.10 Nordic Countries
8 Asia-Pacific
8.1 Asia-Pacific Mantle Cell Lymphoma Treatment Market Size (2019-2030)
8.2 Asia-Pacific Mantle Cell Lymphoma Treatment Market Growth Rate by Region: 2019 VS 2023 VS 2030
8.3 Asia-Pacific Mantle Cell Lymphoma Treatment Market Size by Region (2019-2024)
8.4 Asia-Pacific Mantle Cell Lymphoma Treatment Market Size by Region (2025-2030)
8.5 China
8.6 Japan
8.7 South Korea
8.8 Southeast Asia
8.9 India
8.10 Australia
9 Latin America
9.1 Latin America Mantle Cell Lymphoma Treatment Market Size (2019-2030)
9.2 Latin America Mantle Cell Lymphoma Treatment Market Growth Rate by Country: 2019 VS 2023 VS 2030
9.3 Latin America Mantle Cell Lymphoma Treatment Market Size by Country (2019-2024)
9.4 Latin America Mantle Cell Lymphoma Treatment Market Size by Country (2025-2030)
9.5 Mexico
9.6 Brazil
10 Middle East & Africa
10.1 Middle East & Africa Mantle Cell Lymphoma Treatment Market Size (2019-2030)
10.2 Middle East & Africa Mantle Cell Lymphoma Treatment Market Growth Rate by Country: 2019 VS 2023 VS 2030
10.3 Middle East & Africa Mantle Cell Lymphoma Treatment Market Size by Country (2019-2024)
10.4 Middle East & Africa Mantle Cell Lymphoma Treatment Market Size by Country (2025-2030)
10.5 Turkey
10.6 Saudi Arabia
10.7 UAE
11 Key Players Profiles
11.1 Astex Pharmaceuticals, Inc.
11.1.1 Astex Pharmaceuticals, Inc. Company Detail
11.1.2 Astex Pharmaceuticals, Inc. Business Overview
11.1.3 Astex Pharmaceuticals, Inc. Mantle Cell Lymphoma Treatment Introduction
11.1.4 Astex Pharmaceuticals, Inc. Revenue in Mantle Cell Lymphoma Treatment Business (2019-2024)
11.1.5 Astex Pharmaceuticals, Inc. Recent Development
11.2 Bayer AG
11.2.1 Bayer AG Company Detail
11.2.2 Bayer AG Business Overview
11.2.3 Bayer AG Mantle Cell Lymphoma Treatment Introduction
11.2.4 Bayer AG Revenue in Mantle Cell Lymphoma Treatment Business (2019-2024)
11.2.5 Bayer AG Recent Development
11.3 Bristol-Myers Squibb Company
11.3.1 Bristol-Myers Squibb Company Company Detail
11.3.2 Bristol-Myers Squibb Company Business Overview
11.3.3 Bristol-Myers Squibb Company Mantle Cell Lymphoma Treatment Introduction
11.3.4 Bristol-Myers Squibb Company Revenue in Mantle Cell Lymphoma Treatment Business (2019-2024)
11.3.5 Bristol-Myers Squibb Company Recent Development
11.4 Celgene Corporation
11.4.1 Celgene Corporation Company Detail
11.4.2 Celgene Corporation Business Overview
11.4.3 Celgene Corporation Mantle Cell Lymphoma Treatment Introduction
11.4.4 Celgene Corporation Revenue in Mantle Cell Lymphoma Treatment Business (2019-2024)
11.4.5 Celgene Corporation Recent Development
11.5 Cellular Biomedicine Group, Inc.
11.5.1 Cellular Biomedicine Group, Inc. Company Detail
11.5.2 Cellular Biomedicine Group, Inc. Business Overview
11.5.3 Cellular Biomedicine Group, Inc. Mantle Cell Lymphoma Treatment Introduction
11.5.4 Cellular Biomedicine Group, Inc. Revenue in Mantle Cell Lymphoma Treatment Business (2019-2024)
11.5.5 Cellular Biomedicine Group, Inc. Recent Development
11.6 Eisai
11.6.1 Eisai Company Detail
11.6.2 Eisai Business Overview
11.6.3 Eisai Mantle Cell Lymphoma Treatment Introduction
11.6.4 Eisai Revenue in Mantle Cell Lymphoma Treatment Business (2019-2024)
11.6.5 Eisai Recent Development
11.7 EpiZyme, Inc.
11.7.1 EpiZyme, Inc. Company Detail
11.7.2 EpiZyme, Inc. Business Overview
11.7.3 EpiZyme, Inc. Mantle Cell Lymphoma Treatment Introduction
11.7.4 EpiZyme, Inc. Revenue in Mantle Cell Lymphoma Treatment Business (2019-2024)
11.7.5 EpiZyme, Inc. Recent Development
11.8 Fate Therapeutics, Inc.
11.8.1 Fate Therapeutics, Inc. Company Detail
11.8.2 Fate Therapeutics, Inc. Business Overview
11.8.3 Fate Therapeutics, Inc. Mantle Cell Lymphoma Treatment Introduction
11.8.4 Fate Therapeutics, Inc. Revenue in Mantle Cell Lymphoma Treatment Business (2019-2024)
11.8.5 Fate Therapeutics, Inc. Recent Development
11.9 Genentech, Inc.
11.9.1 Genentech, Inc. Company Detail
11.9.2 Genentech, Inc. Business Overview
11.9.3 Genentech, Inc. Mantle Cell Lymphoma Treatment Introduction
11.9.4 Genentech, Inc. Revenue in Mantle Cell Lymphoma Treatment Business (2019-2024)
11.9.5 Genentech, Inc. Recent Development
11.10 Gilead Sciences, Inc.
11.10.1 Gilead Sciences, Inc. Company Detail
11.10.2 Gilead Sciences, Inc. Business Overview
11.10.3 Gilead Sciences, Inc. Mantle Cell Lymphoma Treatment Introduction
11.10.4 Gilead Sciences, Inc. Revenue in Mantle Cell Lymphoma Treatment Business (2019-2024)
11.10.5 Gilead Sciences, Inc. Recent Development
11.11 GlaxoSmithKline Plc
11.11.1 GlaxoSmithKline Plc Company Detail
11.11.2 GlaxoSmithKline Plc Business Overview
11.11.3 GlaxoSmithKline Plc Mantle Cell Lymphoma Treatment Introduction
11.11.4 GlaxoSmithKline Plc Revenue in Mantle Cell Lymphoma Treatment Business (2019-2024)
11.11.5 GlaxoSmithKline Plc Recent Development
11.12 Hutchison MediPharma Limited
11.12.1 Hutchison MediPharma Limited Company Detail
11.12.2 Hutchison MediPharma Limited Business Overview
11.12.3 Hutchison MediPharma Limited Mantle Cell Lymphoma Treatment Introduction
11.12.4 Hutchison MediPharma Limited Revenue in Mantle Cell Lymphoma Treatment Business (2019-2024)
11.12.5 Hutchison MediPharma Limited Recent Development
11.13 ImmunoGen, Inc.
11.13.1 ImmunoGen, Inc. Company Detail
11.13.2 ImmunoGen, Inc. Business Overview
11.13.3 ImmunoGen, Inc. Mantle Cell Lymphoma Treatment Introduction
11.13.4 ImmunoGen, Inc. Revenue in Mantle Cell Lymphoma Treatment Business (2019-2024)
11.13.5 ImmunoGen, Inc. Recent Development
11.14 Immunomedics, Inc.
11.14.1 Immunomedics, Inc. Company Detail
11.14.2 Immunomedics, Inc. Business Overview
11.14.3 Immunomedics, Inc. Mantle Cell Lymphoma Treatment Introduction
11.14.4 Immunomedics, Inc. Revenue in Mantle Cell Lymphoma Treatment Business (2019-2024)
11.14.5 Immunomedics, Inc. Recent Development
12 Analyst's Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.2 Data Source
13.2 Disclaimer
13.3 Author Details